Zai Lab (ZLAB) Cash from Financing Activities (2020 - 2026)

Zai Lab's (ZLAB) quarterly Cash from Financing Activities came in at $5.6 million in Q1 2026, down 87.08% year-on-year from $43.1 million in Q1 2025, and up 1396.05% quarter-over-quarter from -$430000.0 in Q4 2025.

Zai Lab (ZLAB) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Zai Lab has disclosed Cash from Financing Activities across 7 years of filings, most recently posting $5.6 million for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at $5.6 million, down 87.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.8 million (down 89.93% YoY), and the FY2025 annual result was $72.4 million, down 79.32% from the prior year.
  • Cash from Financing Activities came in at $5.6 million for Q1 2026 at Zai Lab, up from -$430000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $237.8 million in Q4 2024 to a low of -$3.9 million in Q1 2023.
  • The 5-year median for Cash from Financing Activities is $709000.0 (2022), against an average of $24.7 million.
  • Across the five-year window, Cash from Financing Activities plunged 1606.2% in 2023 and surged 60411.96% in 2024, its largest moves.
  • Zai Lab's Cash from Financing Activities stood at -$199000.0 in 2022, then soared by 297.49% to $393000.0 in 2023, then soared by 60411.96% to $237.8 million in 2024, then tumbled by 100.18% to -$430000.0 in 2025, then surged by 1396.05% to $5.6 million in 2026.
  • The last three Cash from Financing Activities figures came in at $5.6 million (Q1 2026), -$430000.0 (Q4 2025), and $20.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Zai Lab 20.15 Bn 20.05 Bn 61.30 Mn 5.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.57 Mn
Mar 31, 2026 5.57 Mn
Dec 31, 2025 -430,000.00
Dec 31, 2025 -430,000.00
Sep 30, 2025 20.79 Mn
Sep 30, 2025 20.79 Mn
Jun 30, 2025 8.85 Mn
Jun 30, 2025 8.85 Mn
Mar 31, 2025 43.14 Mn
Mar 31, 2025 43.14 Mn
Dec 31, 2024 237.81 Mn
Dec 31, 2024 237.81 Mn
Sep 30, 2024 42.21 Mn
Sep 30, 2024 42.21 Mn
Jun 30, 2024 22.32 Mn
Jun 30, 2024 22.32 Mn
Mar 31, 2024 47.55 Mn
Mar 31, 2024 47.55 Mn
Dec 31, 2023 393,000.00
Dec 31, 2023 393,000.00